CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Bimalleolar Ankle Fractures

In brief

The OL1000 is intended to be used as a non-invasive adjunctive treatment for adult males or females that have sustained a closed, unstable ankle fracture that requires surgical treatment for stabilization. The initiation of the adjunctive treatment is to begin within 11 days of surgical stabilization.

Key facts

Study ID
NCT02688855
Run by
Encore Medical, L.P.
People needed
217
Starts
2017-01-23
Expected to finish
2022-06-01
Last updated by the study team
2022-03-21

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.